A retrospective, observational study to evaluate increased bone mineral density in postmenopausal women with osteoporosis receiving denosumab.

Trial Profile

A retrospective, observational study to evaluate increased bone mineral density in postmenopausal women with osteoporosis receiving denosumab.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Dec 2016

At a glance

  • Drugs Denosumab (Primary)
  • Indications Osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Dec 2016 Results of real-world chart review (n=222) study published in the Drugs in R and D
    • 21 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top